type here...

CATEGORIES

Press Release

LATEST

1...345...12Page 4 of 12

TRENDING

EDITORS CHOICE

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

Medika Life -
The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

Texas Food Relief with NCS Group and #BStrong Initiative Deliver Food Aid Across Texas

Medika Life -
Each NCS Group Unlimited Carrier Fleet Vehicle brings a total of $180K+ worth of supplies and aid, and a total of six trucks are arriving in Texas

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life -
FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories